COCP Earnings

Quarterly EPS
$-0.49
Q3 2024
$-0.32
Q4 2024
$-0.23
Q1 2025
$-0.20
Q2 2025
$-0.19
Q3 2025
$-0.18
Q4 2025
$-0.17
Q1 2026
$-0.23
Q2 2026
Latest Revenue105.0K
Latest Net Income-3164000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.23105.0K-3164000-15.0%
Q1 2026-$0.17225.0K-2299000+26.1%
Q4 2025-$0.180-2426000+43.8%
Q3 2025-$0.190-2049000+61.2%
Q2 2025-$0.200-2055000+62.3%
Q1 2025-$0.230-2301000+41.0%
Q4 2024-$0.320-3266000+27.3%
Q3 2024-$0.490-4939000-19.5%
Q2 2024-$0.530-5343000
Q1 2024-$0.390-3956000
Q4 2023-$0.440-4464000
Q3 2023-$0.410-4165000
Cocrystal Pharma (COCP) — Earnings